Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.
NYS Entity Status
NYS Filing Date
JULY 11, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - DISCOVERY HOLDINGS DEVELOPMENT LLC
AROUND THE WEB
- Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
Tuesday Jun 13, 2017
- Land Rover Makes 'Uncharted Discoveries'
Friday Jun 9, 2017
It's a new campaign developed with agencies Mindshare and Spark44 to showcase the brand's newest model Discovery SUV.
- Disney Slapped With Lawsuit Over ‘Guardians of the Galaxy,’ ‘Avengers: Age of Ultron’ Effects
By Tim Kenneally, provided by
- Monday Jul 17, 2017
Visual effects firm says that Disney contracted with people who stole the technologyThe company was slapped with a lawsuit on Monday by a visual effects company, which claims that its technology was misappropriated for “Beauty and the Beast,” “Guardians of the Galaxy” and Avengers:“[I]n all of the film industry and media accolades about the record-breaking success of ‘Beauty and the Beast,’ and the acclaimed cutting-edge digital MOVA Contour technology that made the film’s success possible, nowhere is it mentioned that the patented and copyright-protected MOVA Contour technology was stolen from its inventor and developer, Rearden LLC, and its owner Rearden Mova LLC,” the suit reads.Nowhere is it mentioned that although Disney had previously contracted with Rearden LLC and its controlled entities on four previous major motion pictures to use MOVA Contour and knew of a Rearden Demand Letter to one of the thieves demanding immediate return of the stolen MOVA Contour system, Disney nonetheless contracted with the thieves to use the stolen MOVA Contour system.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]
- After Wanda Deal, Chinese Property Developer Faces Debt Risk
By SUI-LEE WEE - Friday Jul 14, 2017
Sunac China Holdings has emerged as one of the country’s most prominent white knights, but its debt load has more than doubled.